IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dogwood Therapeutics Inc (DWTX)

CUSIP: 92829J203 | NYSE | Healthcare · Biotechnology | Micro Cap | 31 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ACK Life Sciences Int'l., (Holdings) Inc.
with Sealbond Limited, Conjoint Inc.
28,763,33175.2%+4,098,360Oct 26, 2026No 13F filer matched
13G/AArmistice Capital, LLC3,384,79810.0%

Institutional Holders — Q3 2026

Geode Capital Management, LLC91,708
0.0% of portfolio›$123.8K
UBS Group AG2,791
0.0% of portfolio›$3.8K
Nuveen, LLC1,264
0.0% of portfolio›$1.7K
Oakworth Capital, Inc.762
0.0% of portfolio›$1.0K
Activest Wealth Management120
0.0% of portfolio›$162
Group One Trading LLC9
0.0% of portfolio›$12
Barclays PLC5
0.0% of portfolio›$7
StyleTurnoverLocationFiled
Geode Capital Management, LLC
91,708$123.8K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
2,791$3.8K0.0%CoreMediumZurich, Switzerland2026-11-10
Nuveen, LLC
1,264$1.7K0.0%CoreLowCharlotte, NC2026-11-10
Oakworth Capital, Inc.
762$1.0K0.0%ETFLowBirmingham, AL2026-10-26
Activest Wealth Management
120$1620.0%ETFLowAventura, FL2026-10-15
Group One Trading LLC
9$120.0%ValueVery HighChicago, IL2026-11-10
Barclays PLC
5$70.0%GrowthMediumLondon, United Kingdom2026-11-06
New 5%+ stake
Jun 30, 2026
No 13F filer matched
13D/ACK Life Sciences Int'l., (Holdings) Inc.28,763,331
75.2% of class · Oct 26, 2026+4,098,360
with Sealbond Limited, Conjoint Inc.
No 13F filer matched
13G/AArmistice Capital, LLC3,384,798
10.0% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched